Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study (Q33365345)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study |
scientific article |
Statements
1 reference
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study (English)
1 reference
Chris Twelves
1 reference
Thomas Cerny
1 reference
Catherine Terret
1 reference
Jantien Wanders
1 reference
Binh Nguyen Bui
1 reference
Dagmar Hess
1 reference
Jean-Pierre Droz
1 reference
Pierre Fumoleau
1 reference
1 March 2005
1 reference
1 reference
41
1 reference
702-707
1 reference
Identifiers
1 reference
1 reference